Nektar Therapeutics Inc. (NKTR)
NASDAQ · Healthcare
Nektar Therapeutics Inc. annual/quarterly total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Nektar Therapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 190.6M, a 21.61% decrease year-over-year.
- Nektar Therapeutics Inc. total liabilities for 2025 were 190.6M, a 21.61% decrease from 2024.
- Nektar Therapeutics Inc. total liabilities for 2024 were 243.1M, a 8.96% decrease from 2023.
- Nektar Therapeutics Inc. total liabilities for 2023 were 267.0M, a 22.36% decrease from 2022.
- Nektar Therapeutics Inc. total liabilities for 2022 were 344.0M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Nektar Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $191 |
| 2024 | $243 |
| 2023 | $267 |
| 2022 | $344 |
| 2021 | $438 |
| 2020 | $461 |
| 2019 | $572 |
| 2018 | $433 |
| 2017 | $421 |
| 2016 | $481 |
| 2015 | $492 |
| 2014 | $405 |
| 2013 | $524 |
| 2012 | $451 |
| 2011 | $409 |
| Nektar Therapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $191 |
| 2024-12-31 | $243 |
| 2023-12-31 | $267 |
| 2022-12-31 | $344 |
| 2021-12-31 | $438 |
| 2020-12-31 | $461 |
| 2019-12-31 | $572 |
| 2018-12-31 | $433 |
| 2017-12-31 | $421 |
| 2016-12-31 | $481 |
| 2015-12-31 | $492 |
| 2014-12-31 | $405 |
| 2013-12-31 | $524 |
| 2012-12-31 | $451 |
| 2011-12-31 | $409 |
| 2010-12-31 | $431 |
Nektar Therapeutics Inc. Total Liabilities — FAQ
Nektar Therapeutics Inc. (NKTR) total liabilities over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NKTR's total liabilities history?
The chart and table above show Nektar Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.